Understanding pulmonary hypertension: the need for an integrative metabolomics and transcriptomics approach

An integrated transcriptomics- and metabolomics-based approach in pulmonary hypertension overcomes single-omics challenges in understanding the complex disease mechanism thereby enabling identification of potential therapeutic/diagnostic targets.